Literature DB >> 9548073

Repertoire breadth of human CD4+ T cells specific for HIV gp120 and p66 (primary antigens) or for PPD and tetanus toxoid (secondary antigens)

G Li Pira1, L Oppezzi, M Seri, M Westby, F Caroli, D Fenoglio, F Lancia, A Ferraris, L Bottone, M T Valle, A Kunkl, G Romeo, A G Dalgleish, F Manca.   

Abstract

Antigen derived peptides bound on MHC class II molecules on presenting cells stimulate specific CD4 lymphocytes that are in a naive state if antigen is given for the first time, or in a memory state if antigen has been previously encountered. In order to compare clonal heterogeneity of the human CD4+ T helper repertoire in primary vs. recall responses, we have generated T cell lines in vitro by repeated stimulation of peripheral lymphocytes with primary or with recall antigens. Clonal heterogeneity was broad in the case of recall response to tetanus toxoid or PPD, with a high frequency of specific precursors (> 100 cells/10(6) lymphocytes). In contrast, T cell lines responsive to primary antigens (HIV gp120 or HIV p66) were oligoclonal as defined by TCR V beta gene usage and by spectratyping, and the precursor frequency was low (< 2 cells/10(6) lymphocytes). Primary T cell lines generated from blood samples drawn at different times from the same donor showed that clones with identical TCR CDR3 region coding sequences were expanded, suggesting that in these individuals a large progeny derived from one single precursor is present, even though a previous encounter with the antigen was not documented. Assuming an even in vivo distribution of such cells, the presence of one precursor every 10(6) CD4 lymphocytes (within the CD4 T repertoire that comprises roughly 10(11) CD4 T cells) indicates that approximately 10(5) identical T cells from the same clonal precursor account for the primary response against the model antigens we have studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548073     DOI: 10.1016/s0198-8859(98)00004-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Ex vivo monitoring of antigen-specific CD4+ T cells after recall immunization with tetanus toxoid.

Authors:  Catherine Barbey; Estelle Pradervand; Nathalie Barbier; François Spertini
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

2.  Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Nadia Starc; Fabiola Landi; Franco Locatelli; Sergio Rutella; Gino Tripodi; Fabrizio Manca
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

3.  Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85.

Authors:  M T Valle; A M Megiovanni; A Merlo; G Li Pira; L Bottone; G Angelini; L Bracci; L Lozzi; K Huygen; F Manca
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals.

Authors:  G Li Pira; D Fenoglio; L Bottone; P Terranova; E Pontali; F Caroli; M Seri; J-C Cailliez; G Koopman; R Accolla; F del Galdo; G Abbate; R de Palma; F Manca
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  T cell receptor usage in patients with non-progressing HIV infection.

Authors:  M D Bodman-Smith; I Williams; R Johnstone; A Boylston; P M Lydyard; A Zumla
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

6.  Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.

Authors:  Trygve Holmøy; Espen Østhagen Kvale; Frode Vartdal
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.